In the Margins

United CEO's illness highlights boards' disclosure quandry

October 19, 2015

By The Wall Street Journal

Boards often wrestle with how and when to tell shareholders when a CEO is experiencing a disabling illness. Companies typically don't reveal a CEO's health problems until a condition reaches a critical stage, and the board of United Continental Holdings has been less than forthcoming following CEO Oscar Munoz's heart attack on Oct. 15. Read the original story from The Wall Street Journal

 

 

Most Read

Viewpoints
Op-Ed: Whither valuation guidance?

The Securities and Exchange Commission should issue valuation guidance for investment companies. When I was chief counsel in the SEC's Division of Investment Management from 1997 ...